Description
GLP-MAX™ (Reta / Cargi)
15MG / 2.5MG
Advanced Metabolic Research Blend
GLP-MAX™ is a next-generation dual-pathway research compound combining a triple-agonist metabolic modulator with an amylin analog in one precision-measured vial.
Designed for advanced metabolic research environments, this formulation explores the synergistic interaction between GLP pathway activation and amylin receptor modulation.
